{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:16:31Z","timestamp":1790270191178,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>In recent years, the controlled nutritional status (CONUT) score has been widely recognized as a new indicator for assessing survival in patients with urological neoplasms, including renal, ureteral, and bladder cancer. However, the CONUT score has not been analyzed in patients with HIV-related urological neoplasms. Therefore, we aimed to evaluate the prognostic significance of the CONUT score in patients with HIV-related renal cell carcinoma (RCC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 106 patients with HIV-related RCC were recruited from four hospitals between 2012 and 2021, and all included patients received radical nephrectomy or partial nephrectomy. The CONUT score was calculated by serum albumin, total lymphocyte counts, and total cholesterol concentrations. Patients with RCC were divided into two groups according to the optimal cutoff value of the CONUT score. Survival analysis of different CONUT groups was performed by the Kaplan\u2013Meier method and a log rank test. A Cox proportional risk model was used to test for correlations between clinical variables and cancer-specific survival (CSS), overall survival (OS), and disease-free survival (DFS). Clinical variables included age, sex, hypertension, diabetes, tumor grade, Fuhrman grade, histology, surgery, and CD4+ T lymphocyte count.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>The median age was 51 years, with 93 males and 13 females. At a median follow-up of 41 months, 25 patients (23.6%) had died or had tumor recurrence and metastasis. The optimal cutoff value for the CONUT score was 3, and a lower CONUT score was associated with the Fuhrman grade (P=0.024). Patients with lower CONUT scores had better CSS (HR 0.197, 95% CI 0.077-0.502, P=0.001), OS (HR 0.177, 95% CI 0.070-0.446, P&amp;lt;0.001) and DFS (HR 0.176, 95% CI 0.070-0.444, P&amp;lt;0.001). Multivariate Cox regression analysis indicated that a low CONUT score was an independent predictor of CSS, OS and DFS (CSS: HR=0.225, 95% CI 0.067-0.749, P=0.015; OS: HR=0.201, 95% CI 0.061-0.661, P=0.008; DFS: HR=0.227, 95% CI 0.078-0.664, P=0.007). In addition, a low Fuhrman grade was an independent predictor of CSS (HR 0.192, 95% CI 0.045-0.810, P=0.025), OS (HR 0.203, 95% CI 0.049-0.842, P=0.028), and DFS (HR 0.180, 95% CI 0.048-0.669, P=0.010), while other factors, such as age, sex, hypertension, diabetes, tumor grade, histology, surgery, and CD4+ T lymphocyte count, were not associated with survival outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The CONUT score, an easily measurable immune-nutritional biomarker, may provide useful prognostic information in HIV-related RCC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.778746","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:15:11Z","timestamp":1638382511000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Wenrui","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","article-title":"Renal Cancer","volume":"387","author":"Capitanio","year":"2016","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU Guidelines on Renal Cell Carcinoma: 2014 Update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02485","article-title":"Dendritic Cells, the Double Agent in the War Against HIV-1","volume":"10","author":"Mart\u00edn-Moreno","year":"2019","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2013.230","article-title":"Urological Aspects of HIV and AIDS","volume":"10","author":"Heyns","year":"2013","journal-title":"Nat Rev Urol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12885-015-1099-y","article-title":"Risk of Cancer Among HIV-Infected Patients From a Population-Based Nested Case-Control Study: Implications for Cancer Prevention","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12199-020-00881-6","article-title":"Immunological Status and Virological Suppression Among HIV-Infected Adults on Highly Active Antiretroviral Therapy","volume":"25","author":"Melku","year":"2020","journal-title":"Environ Health Prev Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/QAD.0b013e328317cc2d","article-title":"Trends in the Incidence of Cancers Among HIV-Infected Persons and the Impact of Antiretroviral Therapy: A 20-Year Cohort Study","volume":"23","author":"Crum-Cianflone","year":"2009","journal-title":"AIDS"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013409","article-title":"Prognostic Impact of the Controlling Nutritional Status Score Following Curative Nephrectomy for Patients With Renal Cell Carcinoma","volume":"97","author":"Zheng","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.21037\/apm.2020.04.31","article-title":"The Prognostic Value of Prognostic Nutritional Index (PNI) and Neutrophil to Lymphocyte Ratio (NLR) for Advanced non-Small Cell Lung Cancer Treated With Platinum-Based Chemotherapeutics","volume":"9","author":"Wang","year":"2020","journal-title":"Ann Palliat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.02.003","article-title":"The Neutrophil- to-Lymphocyte Ratio (NLR) Predicts Short-Term and Long-Term Outcomes in Gastric Cancer Patients","volume":"44","author":"Miyamoto","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01562","article-title":"The Value of Prognostic Nutritional Index (PNI) in Predicting Survival and Guiding Radiotherapy of Patients With T1-2n1 Breast Cancer","volume":"9","author":"Hua","year":"2020","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-019-01461-7","article-title":"Clinical Significance of Prognostic Nutritional Index (PNI) in Malignant Melanoma","volume":"24","author":"Mirili","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1186\/s12885-016-2696-0","article-title":"The Pretreatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Patients With Resectable Thoracic Esophageal Squamous Cell Carcinoma: Results From a Retrospective Study","volume":"16","author":"Toyokawa","year":"2016","journal-title":"BMC Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2147\/HIV.S9069","article-title":"The Effect of Aging, Nutrition, and Exercise During HIV Infection","volume":"2","author":"Somarriba","year":"2010","journal-title":"HIV AIDS (Auckl)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.20960\/nh.453","article-title":"Nutritional Status and Quality of Life in HIV-Infected Patients","volume":"34","author":"De Carvalho","year":"2017","journal-title":"Nutr Hosp"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1089\/AID.2019.0285","article-title":"Higher Proportion of Abnormal Nutritional Status Among Well-Suppressed HIV-Infected Elderly Asians Compared to HIV-Negative Individuals","volume":"36","author":"Apornpong","year":"2020","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665108006095","article-title":"HIV\/AIDS: Nutritional Implications and Impact on Human Development","volume":"67","author":"Colecraft","year":"2008","journal-title":"Proc Nutr Soc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.clnu.2012.06.010","article-title":"Sarcopenic Obesity: A Critical Appraisal of the Current Evidence","volume":"31","author":"Prado","year":"2012","journal-title":"Clin Nutr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2017.04.012","article-title":"Preoperative Controlling Nutritional Status (CONUT) Score as a Novel Predictive Biomarker of Survival in Patients With Localized Urothelial Carcinoma of the Upper Urinary Tract Treated With Radical Nephroureterectomy","volume":"35","author":"Ishihara","year":"2017","journal-title":"Urol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2018.1490448","article-title":"Prognostic Impact of Nutritional Status Assessed by the Controlling Nutritional Status (CONUT) Score in Patients With Surgically Treated Renal Cell Carcinoma","volume":"70","author":"Kang","year":"2018","journal-title":"Nutr Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1902","article-title":"Validation of the Preoperative Controlling Nutritional Status Score as an Independent Predictor in a Large Chinese Cohort of Patients With Upper Tract Urothelial Carcinoma","volume":"7","author":"Xu","year":"2018","journal-title":"Cancer Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-019-02846-x","article-title":"Preoperative Controlling Nutritional Status (CONUT) Score as a Novel Immune-Nutritional Predictor of Survival in non-Metastatic Clear Cell Renal Cell Carcinoma of \u2264\u20097 Cm on Preoperative Imaging","volume":"145","author":"Elghiaty","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S209418","article-title":"The Prognostic Value of Preoperative Controlling Nutritional Status Score in Non-Metastatic Renal Cell Carcinoma Treated With Surgery: A Retrospective Single-Institution Study","volume":"11","author":"Song","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S225711","article-title":"High Preoperative Controlling Nutritional Status Score Predicts a Poor Prognosis in Patients With Localized Upper Tract Urothelial Cancer: A Propensity Score Matching Study in a Large Chinese Center","volume":"12","author":"Bao","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001196","article-title":"Prognostic Significance of the Controlling Nutritional Status (CONUT) Score in Patients With Advanced Renal Cell Carcinoma Treated With Nivolumab After Failure of Prior Tyrosine Kinase Inhibitors","volume":"204","author":"Takemura","year":"2020","journal-title":"J Urol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in Underlying Causes of Death in People With HIV From 1999 to 2011 (D:A:D): A Multicohort Collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8553(05)70300-9","article-title":"Surgical Risk Assessment and Management in Patients With HIV Disease","volume":"26","author":"Harris","year":"1997","journal-title":"Gastroenterol Clin N Am"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2014.07.074","article-title":"Outcomes of Patients With Human Immunodeficiency Virus Infection Undergoing Cardiovascular Surgery in the United States","volume":"148","author":"Robich","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s12032-014-0282-3","article-title":"A Discussion of Serum Albumin Level in Advanced-Stage Hepatocellular Carcinoma: A Medical Oncologist's Perspective","volume":"31","author":"Tanriverdi","year":"2014","journal-title":"Med Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/aid.2006.22.14","article-title":"Serum Albumin as a Prognostic Indicator for HIV Disease Progression","volume":"22","author":"Mehta","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/00126334-200305010-00010","article-title":"Serum Albumin Is a Powerful Predictor of Survival Among HIV-1-Infected Women","volume":"33","author":"Feldman","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit027","article-title":"Association of Serum Albumin Concentration With Mortality, Morbidity, CD4 T-Cell Reconstitution Among Tanzanians Initiating Antiretroviral Therapy","volume":"207","author":"Sudfeld","year":"2013","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11519-4","article-title":"Markers of HIV-1 Disease Progression in Individuals With Haemophilia Coinfected With Hepatitis C Virus: A Longitudinal Study","volume":"360","author":"Sabin","year":"2002","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205","article-title":"Cancer-Related Inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/89.7.505","article-title":"CD4 and Total Lymphocyte Counts as Predictors of HIV Disease Progression","volume":"89","author":"Post","year":"1996","journal-title":"QJM"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200309260-00004","article-title":"Rapid Declines in Total Lymphocyte Counts and Hemoglobin Concentration Prior to AIDS Among HIV-1-Infected Men","volume":"17","author":"Lau","year":"2003","journal-title":"AIDS"},{"key":"B37","first-page":"94","article-title":"Total Lymphocyte Count of 1200 Is Not a Sensitive Predictor of CD4 Lymphocyte Count Among Patients With HIV Disease in Kampala, Uganda","volume":"4","author":"Kamya","year":"2004","journal-title":"Afr Health Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.189464","article-title":"Desmosome Assembly and Cell-Cell Adhesion are Membrane Raft-Dependent Processes","volume":"286","author":"Resnik","year":"2011","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.09.025","article-title":"Impact of HIV and Highly Active Antiretroviral Therapy on Leukocyte Adhesion Molecules, Arterial Inflammation, Dyslipidemia, and Atherosclerosis","volume":"185","author":"Fisher","year":"2006","journal-title":"Atherosclerosis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.100.7.700","article-title":"Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors. The Swiss HIV Cohort Study","volume":"100","author":"P\u00e9riard","year":"1999","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ Count-Guided Interruption of Antiretroviral Treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1590\/s0066-782x2007000700002","article-title":"IV Diretriz Brasileira Sobre Dislipidemias E Preven\u00e7\u00e3o Da Aterosclerose: Departamento De Aterosclerose Da Sociedade Brasileira De Cardiologia [IV Brazilian Guideline for Dyslipidemia and Atherosclerosis Prevention: Department of Atherosclerosis of Brazilian Society of Cardiology]","author":"Sposito","year":"2007","journal-title":"Arq Bras Cardiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","article-title":"Hyperlipidemia and Insulin Resistance are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1086\/339866","article-title":"Factors Related to Lipodystrophy and Metabolic Alterations in Patients With Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy","volume":"34","author":"Sav\u00e8s","year":"2002","journal-title":"Clin Infect Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1186\/s12889-018-5852-4","article-title":"Associations of Gender and Serum Total Cholesterol With CD4+ T Cell Count and HIV RNA Load in Antiretroviral-Na\u00efve Individuals in Addis Ababa","volume":"18","author":"Adal","year":"2018","journal-title":"BMC Public Health"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20315","article-title":"Breast Cancer Among HIV-Infected Patients: The Experience of the European Institute of Oncology","volume":"91","author":"Intra","year":"2005","journal-title":"J Surg Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0614","article-title":"Are HIV-Infected Men Vulnerable to Prostate Cancer Treatment Disparities","volume":"23","author":"Murphy","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12487","article-title":"HIV and Renal Cell Carcinoma: Experience in an Australian Statewide HIV Center","volume":"12","author":"Ong","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32832f3e04","article-title":"Targeted Therapies to Treat non-AIDS-Defining Cancers in Patients With HIV on HAART Therapy: Treatment Considerations and Research Outlook","volume":"21","author":"Deeken","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31817ae5da","article-title":"Kidney and Bladder Cancers Among People With AIDS in the United States","volume":"48","author":"Layman","year":"2008","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.778746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:15:15Z","timestamp":1638382515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.778746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2021.778746"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.778746","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"article-number":"778746"}}